Skip to content
MarketScale
‹ Back to IndustriesHealthcare

Autism and the Benefits of Early Intervention

The number of people diagnosed with autism spectrum disorder (ASD) continues to rise at a steady pace. Recent studies estimate that 1% to 2% of individuals worldwide have been diagnosed with autism, and in the United States alone, one out of every 59 children is on the spectrum.1 Despite these growing numbers, there is good news….

This story was produced through MarketScale. See how Healthcare teams put it to work with Executive Thought Leadership.

Share

Get featured

Want to get featured in MarketScale Healthcare?

Create a free MarketScale workspace and get your company's expertise featured across our Healthcare coverage. No credit card, no demo required.

Request an invite

The number of people diagnosed with autism spectrum disorder (ASD) continues to rise at a steady pace. Recent studies estimate that 1% to 2% of individuals worldwide have been diagnosed with autism, and in the United States alone, one out of every 59 children is on the spectrum.1 Despite these growing numbers, there is good news. Research shows that early behavioral intervention therapies can improve cognitive and language skills and create positive changes in social responsiveness.2 However, neuroplasticity decreases as children get older, making them less receptive to such therapy and therefore increasing the importance of early intervention.

Early Intervention is the Most Effective Way to Address Autism

As rates of ASD increase, medical professionals recognize the impact of early intervention, such as the Early Start Denver Model (ESDM), a comprehensive behavioral approach for autistic children age 12 to 48 months.3 Currently, many insurers are reluctant to pay for the care, though this is expected to change as new research suggests the costs associated with the intensive treatment show children needing fewer services over time – decreasing total spend in the long run.4 In a recent ESDM study, after two years of intensive intervention children showed a greater increase in IQ, adaptive functioning, communication, and other measures when compared to the control group.5

A Wide Range of Therapies Can Help Children with ASD

Treatment plans for children on the autism spectrum often include a wide range of techniques and approaches:

  • Applied Behavioral Analysis (ABA)— Applied Behavioral Analysis is a critical component of ESDM. ABA therapy focuses on helping children understand how their actions and skills affect their environment, be it physical or social.6 Products that may help teach early language skills include the Autism and PDD Early Intervention book series, featuring characters that teach critical early language skills, joint attention, and social reciprocity through engaging stories and hands-on activities.
  • Speech and Language Therapy— Some individuals on the autism spectrum do not speak, while others love to talk but find conversation and certain linguistic nuances challenging. It can also be difficult for many with ASD to pick up on nonverbal cues when communicating with others. If begun at an early age, speech and language therapy can help address these challenges. Fewer than 10% of nonverbal children remain nonverbal when following an early intervention program.7 Early Social Behavior BooksElementary Language Processing Tests, and Functional Language Programs for Children are just a few pediatric speech therapy tools that can be used in therapy.
  • Occupational Therapy— Children with autism often have difficulty with both fine and gross motor skills. Catching, running, skipping, and climbing can improve gross motor skills while playing with a variety of textures such as rice, beans, sand, cooked noodles, and specialty products like Color Coded Therapy Putty help in the development of fine motor skills.8
  • Sensory Processing— Children with autism typically exhibit delays and deficits in sensory processing and modulation.9 Input processing can be improved through heavy work-playing games and deep pressure therapy, while vestibular stimulation can be promoted by playing on swings, such as the Skillbuilders™ Swing Seat, using a variety of motions.
  • Physical Therapy— Children with autism, children with autism often need help developing their motor skills or have low muscle tone. A carefully designed program of physical therapy can help improve balance and coordination skills, build muscle for support and endurance, and improve functional mobility and motor skills.11

AliMed Has Products to Help with Early Intervention Therapy

As diagnoses of Autism Spectrum Disorder increase, caregivers, pediatricians, speech therapists, occupational therapists, and physical therapists must have the tools to treat children on the spectrum through early intervention. Learn more about AliMed’s selection of autism products by visiting https://www.alimed.com/autism-products/ today.

REFERENCES

  1. https://www.cdc.gov/ncbddd/autism/data.html
  2. https://www.autismspeaks.org/science/science-news/top-ten-lists/2012/early-intervention-program-alters-brain-activity-children-au
  3. https://www.autismspeaks.org/what-autism/treatment/early-start-denver-model-esdm
  4. https://psychcentral.com/news/2017/08/09/intensive-early-intervention-is-cost-effective-and-beneficial-for-asd/124429.html
  5. https://www.washington.edu/news/2015/06/09/early-intervention-improves-long-term-outcomes-for-children-with-autism
  6. https://www.autismspeaks.org/what-autism/treatment/applied-behavior-analysis-aba
  7. https://www.autismparentingmagazine.com/autism-early-intervention-benefits/
  8. http://cornerstoneautismcenter.com/about-autism/ot-sensory-ideas-home/
  9. http://cornerstoneautismcenter.com/about-autism/ot-sensory-ideas-home/
  10. https://www.carautismroadmap.org/the-role-of-the-pediatric-physical-therapist-for-children-with-autism-spectrum-disorder/
  11. https://www.carautismroadmap.org/the-role-of-the-pediatric-physical-therapist-for-children-with-autism-spectrum-disorder/

Read more at alimed.com

Your experts belong here

Every story in MarketScale Healthcare starts with a company putting its clinicians, service-line leaders, and field engineers on the record. Buyers are already reading this topic. The only question is whose experts they find.

Service-line buyers vet vendors quietly, and your clinicians become the proof they find while doing it.

Get your team featuredSee how it works15 minutes, straight to a calendar.

Follow Healthcare Insights

Get new expert content in your inbox.

Healthcare: are you visible to AI?

Before they reach out, Healthcare buyers ask AI engines which vendors to trust. See how AI describes your company today, and where competitors show up instead.

Free workspace

You just read one Healthcare expert. Your company is full of them.

This article was produced through MarketScale. The same platform turns your clinicians, service-line leaders, and field engineers into the articles, video, and social content Healthcare buyers are searching for. Create a free workspace and see it with your own people. No credit card, no demo required.

NPS +73 · 1,000+ creators · 38+ countries

What you get, free

Your own MarketScale Studio workspace
One video edit a month, on us
AI writing, editing, and publishing tools
In-platform coaching to learn the system

More Healthcare Insights

Interchangeable biosimilars are getting approved faster, and Wezlana shows why

Interchangeable biosimilars are getting approved faster, and Wezlana shows why

The FDA approved Wezlana (ustekinumab-auub) as a biosimilar to and interchangeable with Stelara for multiple inflammatory diseases, which means it may be substituted without consulting the prescriber, subject to state pharmacy laws. A Springer analysis reported 26 interchangeable biosimilars approved since 2020 and said average approval timelines decreased from 798 days for applications dated in 2020 to 364 days for applications dated in 2024. The operational pressure shifts to formulary, payer, and specialty pharmacy workflow design.

  • 01Interchangeability is becoming the default ask, not an afterthought: Springer found 17 of 26 approvals pursued interchangeability concurrently, which changes how buyers should time contracting and conversions.
  • 02Springer reported average approval timelines decreased from 798 days for applications dated in 2020 to 364 days for applications dated in 2024, which can compress planning windows for monitoring and implementation.
  • 03A new interchangeable ustekinumab option means the hard work is no longer clinical, it is operational: NDC mapping, EMR preference lists, substitution rules by state, and patient communications decide whether savings show up.

Sep 8, 2026

AAO-HNSF hearing loss guideline moves audiograms and amplification into primary care

AAO-HNSF’s new age-related hearing loss guideline calls for screening adults starting at age 50 and escalating to otoscopy, audiogram, and appropriately fit amplification. It shifts hearing loss from “patient complaint” to a routine primary-care workflow. The pressure shows up in audiology capacity, referral design, and documentation standards.

  • 01Screening at age 50 becomes a repeatable workflow, so capacity planning shifts from episodic ENT referrals to steady primary-care volume, especially where annual wellness visits are a dominant access point.
  • 02The guideline’s escalation sequence, screen, otoscopy, audiogram, amplification, then cochlear implant candidacy evaluation, creates a measurable funnel that health systems can instrument in the EHR and manage like any other pathway.
  • 03Asymmetric loss remains a separate trigger for MRI in many settings, and 2026 pre-proof work using NHANES and SEER highlights why imaging criteria choices can swing scan volume, a budgeting and radiology access issue, not a clinical footnote.

Sep 7, 2026

ADHA shifts My Health Record to multi-supplier ops as Accenture signs new 3-year contract

ADHA shifts My Health Record to multi-supplier ops as Accenture signs new 3-year contract

Accenture will keep supporting Australia’s My Health Record under a new three-year contract. ADHA is moving the platform to a multi-supplier operating model. The shift raises questions about shared integration discipline, tooling, and accountability when changes hit production.

  • 01Multi-supplier delivery is spreading across national-scale health platforms, as ADHA's My Health Record shift shows, moving risk from vendor selection to integration, runbooks, and accountability.
  • 02GenAI model upgrades are arriving with healthcare-specific claims, but the procurement work moves to evidence, safety controls, and monitoring once models sit inside clinical workflows.
  • 03Embedded AI expands the cyber asset inventory problem: if teams cannot discover the AI components across endpoints and devices, they cannot reliably secure or audit them.

Sep 7, 2026

Explore More Healthcare Insights

Read more expert perspectives from across Healthcare.

Browse Healthcare Hub

For B2B teams

Your experts could be publishing here

Stories like this one run on content MarketScale captures from real practitioners. See how your team's expertise becomes coverage in Healthcare and beyond.

Book a 15-minute demo

Or call us. No forms required. We pick up. 214-945-2512